Sofwave Medical (SOFW.TA) Stock Price

Sofwave Medical Price

CLOSED
10.28
​
Market closed

Over the last 4 years Sofwave Medical grew revenue by 93.1% annually, reaching 59.65 M USD. For Sofwave Medical, the net margin of -7.6% is up versus -272.5% a few years ago.

Sofwave Medical stock price

Access this data via the Eulerpool API

Sofwave Medical business model & stock analysis

Sofwave Medical Ltd. engages in development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.

Frequently asked questions about Sofwave Medical

Converted at the current exchange rate, the Sofwave Medical share trades at 9.17 EUR (10.28 USD).

The revenue cannot currently be calculated for Sofwave Medical.

The profit cannot currently be calculated for Sofwave Medical.

The P/E ratio cannot be calculated for Sofwave Medical at the moment.

The P/S cannot be calculated for Sofwave Medical currently.

The Eulerpool Quality Score for Sofwave Medical is 2/10.

The ISIN of Sofwave Medical is IL0011754392. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sofwave Medical is SOFW.TA. The ticker symbol is used to trade Sofwave Medical shares on the stock exchange.

Fair ValueTerminal
9.77 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website sofwave.com
Country
Israel
Currency
USD
Initial public offering
May 18, 2021
ISIN
IL0011754392
Cusip
M9067W114
Market capitalization
371.24 M USDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
15.14
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-17.54 %
Last updated Oct 9, 2026, 9:42 PM

Sofwave Medical Peer Group

Sofwave Medical FIGI

SOFW:IT · BBG0110QLHS7